Introduction
Pheochromocytoma is associated with a variety of diseases, including multiple endocrine neoplasia type 2, various carcinomas, von Recklinghausen's disease, von Hippel Rindau's disease (1), Sturge-Weber's disease, and cholecystolithiasis. Cardiac manifestations of pheochromocytoma, which are seen relatively frequently, result from hypertensive organ damage and/or catecholamine toxicity. Congenital heart disease is a rare complication of pheochromocytoma, especially in Japan (2) , although a possible association between pheochromocytoma and congenital heart disease has been reported in the US (3) (4) (5) . We report two cases of a rare combi-(SHIONORIA BNP; Shionogi, Osaka, Japan). Catecholamine concentrations in the plasma and urine were assessed by high performance liquid chromatography (HPLC). All examinations were performed after obtaining the informed consent of the patients.
Case Reports Case 1
A 45-year-old woman with a history of palliative operation at 14 years of age and radical operation at 20 years of age for tetralogy of Fallot, presented with sudden general fatigue and palpitation. She had been asymptomatic since the radical surgery and she did not have any complications during delivery. On admission, her blood pressure was 200/100 mmHg and crackles were heard in both lung fields. Electrocardiogram showed a complete right bundle branch block associated with ventricular bigeminy and a heart rate of 88 beats/min. Chest radiography on admission revealed cardiomegaly [cardiothoracic ratio (CTR): 68%] with pulmonary congestion. She was initially treated with intravenous injection of furosemide followed by continuous infusion of carperitide. Her blood pressure decreased and all symptoms disappeared on the day following admission. Since then, her blood pressure has remained within the normal range without any medications. Secondary polycythemia was not observed and her erythropoietin level (18.1 mU/ml) remained within the normal range. Cardiac catheterization revealed a small pressure gradient across the pulmonary valve (right ventricular pressure: 48/7 mmHg; pulmonary artery pressure: 35/7 mmHg). Neither a ventricular septal defect nor abnormal O2 step-up was observed and her cardiac function was preserved (cardiac index: 3.3 l/min/m 2 ). Remarkably increased levels of noradrenaline and its metabolite were found in blood and urine samples obtained on admission and in those obtained prior to the surgery (Table 1) . Abdominal CT demonstrated a left adrenal tumor (5 6 cm) (Fig. 1A) , which showed abnormal accumulation on 131 I-metaiodobenzyl guanidine (MIBG) scintigraphy (Fig.  1B) . These data clearly suggested pheochromocytoma in the left adrenal gland. The patient underwent left adrenalectomy after preconditioning with doxazosin, and the diagnosis of pheochromocytoma was confirmed by histopathological examination (Fig. 2) . After the surgery, her blood pressure remained within the normal range without antihypertensive drugs (around 110/70 mmHg), and her elevated plasma noradrenaline level decreased to the normal range (Table 1) .
Case 2
A 41-year-old woman had been suffering from cyanosis due to tetralogy of Fallot throughout her life. A Blalock-Taussig operation had been performed at 7 years of age, but a radical operation had not been performed. Clubbing of the terminal digits was prominent. Chest radiography revealed a bootshaped heart with a prominent right ventricle and concavity in the region of the main pulmonary artery (CTR: 72%). The pulmonary vascular markings in the right lung field were diminished. Two-dimensional echocardiography showed the aorta overriding the ventricular septum (Fig. 3) . Peripheral edema and liver congestion due to right-sided heart failure were occasionally noted, and systemic hypertension was prominent at 38 years of age. She was repeatedly admitted to our hospital between 39 and 40 years of age because of rightsided heart failure combined with labile hypertension, headache, palpitation and excessive sweating. Remarkably increased levels of noradrenaline and its metabolite were first detected in blood and urine samples at 41 years of age (Table 2) . Secondary polycythemia was observed (RBC 922 10 4 /µl, Hb 15.7 g/dl, hematocrit (Hct) 56.1%), and her erythropoietin level was remarkably increased at 675 mU/ml. The presence of a left adrenal tumor was confirmed by abdominal CT and MRI (Fig. 4) . She was diagnosed as having pheochromocytoma, but refused to undergo adrenalectomy. She was treated with oral doxazosin in a multiple-step titration regimen, followed by bisoprolol. Her symptoms gradually improved and her blood pressure decreased from approximately 130-170/70-90 mmHg to 110-130/70-80 mmHg. She has been followed in our outpatient clinic. She has had minimal edema and a slight headache, but her blood pressure is fairly well controlled with 5 mg/day of doxazosin and 5 mg/day of bisoprolol.
Discussion
The incidence of congenital heart disease among all births in Japan has been reported to be 1.06%, and tetralogy of Fallot accounts for 4.5% of all congenital heart diseases in neonatals (7). On the other hand, pheochromocytoma occurs in approximately 0.1% of the hypertensive population (8) , and an even lower rate, approximately 2 cases/1,000,000 people/ year, has been estimated in Japan (2) . Both diseases are wellknown but relatively rare, and thus the probability of their occurring in combination is extremely low. In a report on 493 cases of pheochromocytoma in Japan, there were only two cases of congenital heart disease, one with atrial septal defect and one with patent ductus arteriosus (9). To our knowledge, there has been no reported case of pheochromocytoma in a patient with tetralogy of Fallot in Japan. However, several cases of pheochromocytoma with tetralogy of Fallot have been identified in the US since the 1960s (3) (4) (5) . A significant correlation between congenital heart disease and peripheral neuroblastic tumors-including pheochromocytoma and paragangliomas-has been reported, and the authors of that study estimated that the chronic hypoxia produced by congenital heart disease induced the development of pheochromocytoma (5) . The hypoxic state stimulates catecholamine secretion from the adrenal medulla, and chronic endocrine hyperreactivity may lead to hyperplasia and neoplasia. The rat pheochromocytoma cell line, PC12, is also known as a representative "oxygen-sensing" cell that can adapt to hypoxia (10) . Sustained severe hypoxia may induce the development of pheochromocytoma, and pheochromocytoma might have developed through this mechanism in the second case of the present report. However, this mechanism is not applicable to the first case in this report, because the patient had been cured of hypoxia at 20 years of age. Another factor, such as one of the gene abnormalities associated with primary aldosteronism (11), may also contribute to the development of pheochromocytoma in patients with congenital heart disease. Pheochromocytoma is a tumor that forms on the neural crest-derived adrenal medulla. Neural crest cells also contribute to the formation of the outflow tracts of the heart (12) . Mutations in the neurofibromatosis type 1 (NF1) gene may induce the formation of a variety of tumors of neural crest origin in humans. The NF1 gene codes for neurofibromin, a member of the GAP family of ras regulatory proteins. Mice heterozygous for a targeted mutation in NF1 have been shown to be highly predisposed to the formation of various tumors, notably pheochromocytoma (13) . In the same study, homozygosity for the NF1 mutation led to lethal cardiac malformation in mice (13) . Rapid increases and decreases in the neurofibromin level have been observed during differentiation of the heart in mouse fetal development, particularly during formation of the aorticopulmonary septum leading to formation of the primitive ventricle and during the fusion of the septum primus with the atrioventricular cushion tissue, resulting in formation of the atria (14, 15) . These results suggest the existence of a relationship between pheochromocytoma and congenital heart disease, although the detailed mechanism of the development of pheochromocytoma in patients with congenital heart disease has not been elucidated.
Adrenomedullin was originally isolated from pheochromocytoma tissues and is thought to be involved in the pathogenesis of hypertensive, renal and heart diseases (16) . The plasma adrenomedullin level is also elevated in patients with 
cm). (B) This tumor is irregularly enhanced by gadolinium on MRI.
cyanotic congenital heart disease (17). A markedly increased adrenomedullin level was observed in both cases of the present study, especially during periods when the patients had severe symptoms or abnormal hemodynamic states, and it was well synchronized with the plasma BNP level in each patient. In Case 1, the plasma adrenomedullin level returned to the normal range after stabilization of the hemodynamic state and did not change after removal of the tumor (Table  1) . In Case 2, the plasma adrenomedullin level decreased after pharmacological treatment even though the tumor remained (Table 2 ). These data appear to indicate that the source of the adrenomedullin in patients with pheochromocytoma is not the tumor (18) . The adrenomedullin level seems to reflect the state of hypertension and related heart failure, and these two cases serve as interesting examples for considering the pathophysiological role of adrenomedullin.
In conclusion, we reported two cases of pheochromocytoma combined with tetralogy of Fallot (cyanotic congenital heart disease). This combination is rare, but the two diseases may be related through hypoxia and/or gene abnormalities. The presence of pheochromocytoma necessarily worsens the state of congenital heart disease regardless of whether radical surgery for congenital heart disease has been performed, and pheochromocytoma may be fatal in some cases. The differential diagnosis of pheochromocytoma could be important in congenital heart disease patients who show unexpected or unusual symptoms.
